Yu Y - Search Results

1

Protoporphyrin IX-loaded laminarin nanoparticles for anticancer treatment, their cellular behavior, ROS detection, and animal studies.

Yu Y, Wang B, Guo C, Zhao F, Chen D. Yu Y, et al. Nanoscale Res Lett. 2019 Sep 18;14(1):316. doi: 10.1186/s11671-019-3138-0. Nanoscale Res Lett. 2019. PMID: 31535237 Free PMC article.

2

Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release.

Wang K, Qi M, Guo C, Yu Y, Wang B, Fang L, Liu M, Wang Z, Fan X, Chen D. Wang K, et al. Among authors: yu y. Nanoscale Res Lett. 2018 Feb 2;13(1):32. doi: 10.1186/s11671-018-2445-1. Nanoscale Res Lett. 2018. PMID: 29396830 Free PMC article.

3

Enhanced In Vitro and In Vivo Anticancer Properties by Using a Nanocarrier for Co-Delivery of Antitumor Polypeptide and Curcumin.

Qi M, Zou S, Guo C, Wang K, Yu Y, Zhao F, Fan H, Wu Z, Liu W, Chen D. Qi M, et al. Among authors: yu y. J Biomed Nanotechnol. 2018 Jan 1;14(1):139-149. doi: 10.1166/jbn.2018.2479. J Biomed Nanotechnol. 2018. PMID: 29463371

4

Synthesis, characterization and in vitro/in vivo evaluation of novel reduction-sensitive hybrid nano-echinus-like nanomedicine.

Wang K, Guo C, Zou S, Yu Y, Fan X, Wang B, Liu M, Fang L, Chen D. Wang K, et al. Among authors: yu y. Artif Cells Nanomed Biotechnol. 2018;46(sup2):659-667. doi: 10.1080/21691401.2018.1466147. Epub 2018 Apr 27. Artif Cells Nanomed Biotechnol. 2018. PMID: 29703084 Free article.

5

In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer.

Wang K, Guo C, Dong X, Yu Y, Wang B, Liu W, Chen D. Wang K, et al. Among authors: yu y. Mol Pharm. 2018 Jul 2;15(7):2764-2769. doi: 10.1021/acs.molpharmaceut.8b00266. Epub 2018 Jun 1. Mol Pharm. 2018. PMID: 29792799

6

Synthesis, Characterization and In Vitro Evaluation of Dual pH/Redox Sensitive Marine Laminarin-Based Nanomedicine Carrier Biomaterial for Cancer Therapy.

Yu Y, Zou S, Wang K, Liang R, Fan X, Wang B, Liu M, Fang L, Liu W, Wu Z, Chen D. Yu Y, et al. J Biomed Nanotechnol. 2018 Sep 1;14(9):1568-1577. doi: 10.1166/jbn.2018.2609. J Biomed Nanotechnol. 2018. PMID: 29958551

7

5-fluorouracil-caffeic acid cocrystal delivery agent with long-term and synergistic high-performance antitumor effects.

Yu YM, Bu FZ, Yu Y, Yan CW, Wu ZY, Li YT. Yu YM, et al. Among authors: yu y. Nanomedicine (Lond). 2022 Dec;17(30):2215-2229. doi: 10.2217/nnm-2022-0208. Epub 2023 Mar 17. Nanomedicine (Lond). 2022. PMID: 36927097

8

A novice cocrystal nanomicelle formulation of 5-fluorouracil with proline: The design, self-assembly and in vitro/vivo biopharmaceutical characteristics.

Yu YM, Liu L, Bu FZ, Li YT, Yan CW, Wu ZY. Yu YM, et al. Int J Pharm. 2022 Apr 5;617:121635. doi: 10.1016/j.ijpharm.2022.121635. Epub 2022 Mar 4. Int J Pharm. 2022. PMID: 35257803

9

The first nano-cocrystal formulation of marine drug cytarabine with uracil based on cocrystal nanonization strategy for long-acting injection exhibiting enhanced antitumor activity.

Yu YM, Bu FZ, Meng SS, Yan CW, Wu ZY, Li YT. Yu YM, et al. Int J Pharm. 2023 Sep 25;644:123300. doi: 10.1016/j.ijpharm.2023.123300. Epub 2023 Aug 9. Int J Pharm. 2023. PMID: 37567370

10

Cocrystallization-Driven Double-Optimized Stratagem toward Directional Self-Assembly for the First Ternary Salt Cocrystal of Cardiotonic Drug Milrinone with Different Phenolic Acids Exhibits Optimal In Vitro/Vivo Biopharmaceutical Peculiarities.

Meng SS, Yu YM, Bu FZ, Yan CW, Wu ZY, Li YT. Meng SS, et al. Mol Pharm. 2023 Jul 3;20(7):3598-3612. doi: 10.1021/acs.molpharmaceut.3c00230. Epub 2023 Jun 15. Mol Pharm. 2023. PMID: 37318766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,222 results

Search Page

Filters